The recently FDA-cleared ARTISTE linear accelerator from Siemens Medical has recently gone clinical in three prominent cancer centers around the world, according to Siemens. Dozens of patients have been treated to date at MAASTRO Clinic in the Netherlands, German Cancer Research Center (DKFZ) in Heidelberg, Germany, and Baton Rouge General’s Pennington Cancer Center in Louisiana.
Elekta will debut its eXtend program, a complete system for extending the utilization of Leksell Gamma Knife Perfexion ...
The ProVision Workstation is designed to streamline radiology workflow through its one-click access of the Cerner Multimedia Foundation, a single repository for all types of images across multiple care venues. The system is part of Cerner’s suite of radiology solutions including Integrated Digital Dictation and ProVision Web for integration with the electronic medical record.
Radiology departments have many different needs and face a wide variety of challenges that can impact their departments ...
September 4, 2008 - Merge Healthcare launch its Managed Services initiative, the Merge Off Site Disaster Recovery, which ...
The FDA has granted clearance for GE Healthcare’s newest positron emission tomography/computed tomography (PET/CT) ...
Imaging control capabilities for 3D Conformal, Intensity-Modulated Radiotherapy (IMRT) and dynamic targeting for Image ...
Despite decades of progress in breast imaging, one challenge continues to test even the most skilled radiologists ...
The challenge in radiation therapy is to deliver the optimal amount of dose with enough precision to avoid damaging ...
hilips has introduced new disposable adult ECG leadwire electrodes designed to be easy to use and to allow patient ...
Xoft Inc. recently received FDA clearance for applicators to be used with the Axxent Electronic Brachytherapy System for ...
Bayer Radiology’s Barbara Ruhland and Thom Kinst discuss how radiology departments can address the many different ...
September 4, 2008 – St. Elizabeth, in Cincinnati, OH, which serves more than 300 stroke patients annually, is the first ...
Varian will show at ASTRO its Novalis Tx system, which integrates its Trilogy Tx linear accelerator and new HD120 multi ...
For the Memphis, TN-based Baptist Centers for Cancer Care’s Radiation Oncology Center (BCCC ROC), providing high-quality cancer treatment and customer service translates to not only leading the local and regional pack clinically, competitively and technologically but also consistently.
eHealth Saskatchewan plays a vital role in providing IT services to patients, health care providers, and partners such ...
TQA, or Tomo Quality Assurance, from TomoTherapy Inc. is reportedly the first integrated, machine-specific quality assurance (QA) solution to be offered by a radiation therapy vendor. The TQA application streamlines the collection — and simplifies the review — of data used to monitor radiation therapy equipment and procedures. All TQA data can be exported for third-party validation.
Orfit Industries America’s Efficast thermoplastic mask, part of the Raycast High-precision Patient Immobilization ...
While the DRA has cut short the burgeoning growth of imaging services, particularly those offered by outpatient centers, it also presents other players in the imaging value chain with new opportunities.
September 3, 2008 - US Oncology Inc. launched Innovent Oncology, a service division that offers a first-time opportunity ...
If you look across the total oncology enterprise at most institutions today, you will discover a limited approach to enterprise-wide integration of oncology information management systems (OIMS).
September 4, 2008 - Minutes after the industry’s newest PACS blog, called PACS-aholic (PACS-aholic.blogspot.com), went ...
With the development of 3D-CRT, IMRT, stereotactic approaches and other advanced forms of radiation therapy, imaging has become increasingly important in the field of radiation oncology.
As molecular imaging transitions from undercard modality to mainstream tool in diagnostic imaging, the reality of personalized healthcare appears to be on the horizon. An increasing limelight placed on the modality has attracted both investors and new companies, leading to significant milestones in R&D and thus fulfilling the promise of “true” personalized medicine.
September 03, 2008 